GLUE
Monte Rosa TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
GLUE vs peer average
66/100
GLUE vs. peer average (C vs. D)
Grade spread
B 2 · C 1 · D 2 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABSI is the first available peer comparator.
Loose same-sector market-cap comparator; the packet provides no program-level evidence establishing direct operating comparability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GLUE
Monte Rosa Therapeutics
ABSI
Absci
Grade
C
F
Momentum
2
83
Value
41
41
Sentiment
74
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ABSI
GLUE / ABSI
Grade Position
In line
GLUE vs. peer average (C vs. D)
66/100
Momentum
2
ABSIValue
41
GLUESentiment
74
GLUERotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GLUE
ABSI is the first peer returned for this comparison set.